Cargando…
Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis
Dermatomyositis is a chronic inflammatory disease involving the skin and muscles. It most commonly occurs in adults with preponderance in females, but pediatric occurrence is also possible. The risk of malignancy in adult patients with dermatomyositis was reported to be 4.66-fold higher compared to...
Autores principales: | Marzęcka, Milena, Niemczyk, Anna, Rudnicka, Lidia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464248/ https://www.ncbi.nlm.nih.gov/pubmed/35147864 http://dx.doi.org/10.1007/s12016-022-08922-4 |
Ejemplares similares
-
The Significance of Autoantibodies in Juvenile Dermatomyositis
por: Kwiatkowska, Dominika, et al.
Publicado: (2021) -
Clinical and autoantibody phenotypes of juvenile dermatomyositis
por: Boyarchuk, Oksana, et al.
Publicado: (2022) -
Using autoantibody signatures to define cancer risk in dermatomyositis
por: Turnier, Jessica L., et al.
Publicado: (2022) -
Dermatomyositis and malignancy: should all patients with dermatomyositis undergo malignancy screening?
por: Khanna, Urmi, et al.
Publicado: (2021) -
The Role of Myositis-Specific Autoantibodies in the Dermatomyositis Spectrum
por: Marasandra Ramesh, Harshita, et al.
Publicado: (2022)